Literature DB >> 8352140

High-dose cytarabine neurotoxicity: MR findings during the acute phase.

D J Vaughn1, J G Jarvik, D Hackney, S Peters, E A Stadtmauer.   

Abstract

The authors report an acute cerebral and cerebellar syndrome in a patient treated with high-dose cytarabine. Diffuse high-intensity lesions in the central white matter on T2-weighted MR completely reversed with resolution of the clinical syndrome. Although the autopsy revealed cerebellar injury, the cerebral cortex was grossly and microscopically normal, consistent with a reversible process.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8352140      PMCID： PMC8333830     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  17 in total

1.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Posterior reversible encephalopathy syndrome on computed tomography perfusion in a patient on "Triple H" therapy.

Authors:  Pina C Sanelli; Melissa A Jacobs; Igor Ougorets; Matthew J Mifsud
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness.

Authors:  N Niyadurupola; C A M Burnett; L E Allen
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 5.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

6.  Isolated posterior fossa involvement in posterior reversible encephalopathy syndrome.

Authors:  Yukie Shimizu; Khin Khin Tha; Akihiro Iguchi; Yuko Cho; Atsushi Yoshida; Noriyuki Fujima; Akiko Tsukahara; Hiroki Shirato; Satoshi Terae
Journal:  Neuroradiol J       Date:  2013-11-07

Review 7.  Atypical presentation of posterior reversible encephalopathy syndrome: Clinical and radiological characteristics in eclamptic patients.

Authors:  Aleksandra Aracki-Trenkić; Dragan Stojanov; Milan Trenkić; Zoran Radovanović; Jelena Ignjatović; Saša Ristić; Marija Trenkić-Bozinović
Journal:  Bosn J Basic Med Sci       Date:  2016-06-20       Impact factor: 3.363

8.  Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.

Authors:  H I Tahsildar; B F Remler; R J Creger; B W Cooper; S M Snodgrass; R W Tarr; H M Lazarus
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

9.  Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

10.  Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.